Metraipolis › archive › dc_69eba0427610
Key outcomes in treatment of activated phosphoinositide 3-kinase delta syndrome: An e-Delphi panel study and responder threshold application — Europe PMC PMID:41091701
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41091701
- DOI
- 10.1371/journal.pone.0333341
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T07:25:19.120Z
- SHA-256 of the archived text
b36e095425e7de8a43484d84bdcc8ad54bfe489b7aab26206e284d69dfa859fe- Stable URL of this page
https://metraipolis.com/documento/dc_69eba0427610
How to cite
Key outcomes in treatment of activated phosphoinositide 3-kinase delta syndrome: An e-Delphi panel study and responder threshold application — Europe PMC PMID:41091701 — Europe PMC (en), https://europepmc.org/article/MED/41091701 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69eba0427610 (Metraipolis archive dc_69eba0427610, sha256 b36e095425e7de8a43484d84bdcc8ad54bfe489b7aab26206e284d69dfa859fe)
BibTeX
@misc{dc69eba0427610,
title = {Key outcomes in treatment of activated phosphoinositide 3-kinase delta syndrome: An e-Delphi panel study and responder threshold application — Europe PMC PMID:41091701},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41091701},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69eba0427610; sha256 b36e095425e7de8a43484d84bdcc8ad54bfe489b7aab26206e284d69dfa859fe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41091701. Agents can read the archived copy with the MCP tool read_document.